Sleep peptides

Peptides discussed for sleep and calm; evidence is limited and early.

Tier fingerprint · 2 compounds

S is approval-grade evidence; F is documented harm or near-zero human data. Each bar is how many peptides on this page land in that tier — a fast read on how much of this category sits in approval-grade evidence versus thin or vendor-driven claims.

S
0
A
0
B
0
C
0
D
1
F
1

The category at a glance

Every compound here ranked S–F by its weighted evidence score — strongest human / approval-grade evidence at the top, thin or vendor-driven claims at the bottom. Tap any row for the evidence read. Popularity never raises a tier.

Receipts, not vendor theater. Every tier here is computed from published evidence and regulatory status — not vendor marketing or influencer claims. See how we score.

D
selank
Early human evidenceMedium overstatementResearch-use-only
41
/ 100

A synthetic heptapeptide derived from the immune peptide tuftsin, developed in Russia as an anxiolytic with reported nootropic effects. Human evidence is limited and largely confined to Russian-language studies (e.g. comparison with a benzodiazepine in anxiety); not approved in the US or EU.

Tier read: early human evidence · medium overstatement risk · low search interest · Early human. Why not F: supported by its overall evidence profile. Why not C: held back by human evidence, safety clarity, regulatory clarity, practical relevance.

Read the full selank profile →
F
dsip
Early human evidenceMedium overstatementResearch-use-only
22
/ 100

Delta sleep-inducing peptide, a nonapeptide proposed to promote slow-wave sleep. Across the literature, human sleep results have been inconsistent; it never reached established clinical use and its physiological role remains unresolved.

[1]Acute and delayed effects of DSIP on human sleep behavior (double-blind study)Int J Clin Pharmacol Ther Toxicol, 1981 (PMID 6895513)

Tier read: early human evidence · medium overstatement risk · low search interest · Anecdote. Why not D: held back by human evidence, preclinical depth, mechanism confidence, safety clarity, regulatory clarity, practical relevance.

Read the full dsip profile →

Sleep peptides are a small, early category. DSIP (delta sleep-inducing peptide) is the headline name, but its evidence is old and inconsistent — it is not an established sleep treatment.

Too earlyMostly preclinical or early-stage; human support is thin.
selankD
Research-use-only
High cautionSpeculative, weak human data, or heavily overhyped.
dsipF
Research-use-only
Not proven for this goal
A proven sleep treatmentReplacing sleep hygiene or medical care

What the evidence actually supports

DSIP is an endogenous neuropeptide historically linked to delta-wave sleep and stress modulation; the supporting human work is limited and dated. Selank is sometimes discussed for calm/anxiety rather than sleep per se.

Where the hype outruns the data

Framing any of these as a proven sleep treatment overstates the evidence. They don't replace sleep hygiene or medical evaluation of a sleep problem.

FAQ

Does DSIP work for sleep?

The evidence is old and inconsistent; DSIP is not an established sleep treatment.

Is this medical advice?

No — research reference only.

What should I read first?

Start with the best-supported options on this page, then check each compound's evidence stage and safety notes.

← All goalsFull tier board

Research reference only. Not medical advice, dosing, or a recommendation to use any compound. “Worth watching” ≠ proven or safe.

The all-in-one peptide app

Stop reading, start tracking.

PepCue logs your doses, runs the vial math, counts your vials, and keeps the whole protocol in one place. It replaces the spreadsheet, the calculator, and the sticky notes.

  • Dose logging
  • Reconstitution math
  • Smart reminders
  • Vial & cost tracking
iPhone · free to start